1 / 5
| Customization: | Available |
|---|---|
| Varieties: | Growth Promoting Medicine |
| Component: | Mineral |
GMP Factory Veterinary Medicine Buparvaquone Injection 5%
Composition: Each ml contains Buparvaquone 50mg
Indication: For treatment of tick-transmitted theileriosis caused by intracellular protozoan parasites (Theileria parva, T. annulata) in cattle. Effective against both schizont and piroplasm stages.



| DOSAGE AND ADMINISTRATION | For intramuscular administration. General: 1 ml per 20 kg body weight. In severe cases, repeat within 48-72 hours. Do not exceed 10 ml per site. |
| ADVERSE REACTION | Localized, painless, oedematous swelling may occasionally be seen at the injection site. |
| WITHDRAWAL PERIOD | Meat: 42 days | Milk: 2 days |
| STORAGE | Store dark and below 25°C. Do not freeze. |
| SHELF LIFE | 3 years |
Our facility integrates animal drug research, development, and production. In 2012, we passed the acceptance of eight veterinary drug GMP production lines. Our production includes powder, premix, sterilized small-volume injections, and oral liquid solutions. We are recognized as a standard model factory for veterinary drugs.






SJ medical